Pharmaceutical News

RSS

New effort to support those who fall on the wrong side of global vaccine divide

As SciDev.Net celebrates 20 years of reporting about the impact of science on people in low- and middle-income countries, the need for our work is greater than ever.

4 Jan 2021

Researchers discover novel therapeutic strategy for ischemic stroke using experimental model

Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that a combination of an LSU Health-patented drug and selected DHA derivatives is more effective in protecting brain cells and increasing recovery after stroke than a single drug. The findings are published in Brain Circulation, available here.

4 Jan 2021

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.

3 Jan 2021

WHO lists Comirnaty COVID-19 mRNA vaccine for emergency use

The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.

3 Jan 2021

FDA approves first generic glucagon for injection to treat severe hypoglycemia

Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus.

28 Dec 2020

At risk of extinction, black-footed ferrets get experimental COVID vaccine

In late summer, as researchers accelerated the first clinical trials of COVID-19 vaccines for humans, a group of scientists in Colorado worked to inoculate a far more fragile species.

23 Dec 2020

Congress extends Medicare coverage of immunosuppressive drugs for kidney transplant

An estimated 375 adult kidney transplant recipients lose their transplant every year due to a lack of coverage of immunosuppressive medications after the prior 36-month Medicare coverage period.

23 Dec 2020

Long-term opioid use cannot treat chronic pain, has serious health consequences

A broken heart is often harder to heal than a broken leg. Now researchers say that a broken heart can contribute to lasting chronic pain.

22 Dec 2020

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Immune inflammatory mediators are critical in pathology, transplantation, and regenerative medicine, scientists report in The American Journal of Pathology

22 Dec 2020

Antibiotics for C-sections are effective when given after clamping the umbilical cord

Antibiotics for cesarean section births are just as effective when they're given after the umbilical cord is clamped as before clamping – the current practice – and could benefit newborns' developing microbiomes, according to Rutgers co-authored research.

21 Dec 2020

Study examines effects of social density and intention to vaccinate against COVID-19

Concerns over infecting others play a greater role in people's willingness to be vaccinated in sparsely populated areas than dense urban ones, according to newly published findings in the Proceedings of the National Academy of Sciences (PNAS) of the United States.

21 Dec 2020

Arthritis drug may be effective in treating immunotherapy-related heart complication

A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study published in Cancer Discovery and co-led by investigators at Vanderbilt University Medical Center.

21 Dec 2020

FDA issues first emergency use authorization for second COVID-19 vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

21 Dec 2020

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.

18 Dec 2020

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.

18 Dec 2020

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Healthcare workers in tropical and sub-tropical settings where strongyloidiasis is prevalent or caring for patients who have travelled to such areas, need to maintain a high level of awareness about the use of corticosteroids, including when this class of anti-inflammatories is given to patients suspected of infection with SARS-CoV-2.

17 Dec 2020

Researchers evaluate changes in measles vaccination rates before COVID-19 pandemic

One consequence of the COVID-19 pandemic is that more families are putting off their children's preventive care visits, causing pediatric providers to worry about missed vaccines.

17 Dec 2020

Scientists develop new vaccine to counter the effects of synthetic cannabinoids

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.

17 Dec 2020

4E-BP proteins are key to unlock the antidepressant effect of ketamine in the brain

A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The discovery could lead to better and safer treatments for certain patients suffering from major depression.

17 Dec 2020

TRIUMF and Fusion Pharmaceuticals to develop next-generation radiopharmaceuticals

TRIUMF, Canada's particle accelerator center, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

17 Dec 2020

Pharmaceutical News

New effort to support those who fall on the wrong side of global vaccine divide

Researchers discover novel therapeutic strategy for ischemic stroke using experimental model

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

WHO lists Comirnaty COVID-19 mRNA vaccine for emergency use

FDA approves first generic glucagon for injection to treat severe hypoglycemia

At risk of extinction, black-footed ferrets get experimental COVID vaccine

Congress extends Medicare coverage of immunosuppressive drugs for kidney transplant

Long-term opioid use cannot treat chronic pain, has serious health consequences

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Antibiotics for C-sections are effective when given after clamping the umbilical cord

Study examines effects of social density and intention to vaccinate against COVID-19

Arthritis drug may be effective in treating immunotherapy-related heart complication

FDA issues first emergency use authorization for second COVID-19 vaccine

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

FDA approves first oral drug for treating adult patients with advanced prostate cancer

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Researchers evaluate changes in measles vaccination rates before COVID-19 pandemic

Scientists develop new vaccine to counter the effects of synthetic cannabinoids

4E-BP proteins are key to unlock the antidepressant effect of ketamine in the brain

TRIUMF and Fusion Pharmaceuticals to develop next-generation radiopharmaceuticals

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News